FilingReader Intelligence
Fosun Pharma advances share repurchase, secures EU GMP certification
July 2, 2025 at 05:06 PM UTC•By FilingReader AI
Shanghai Fosun Pharmaceutical Group (SSE:600196) has announced the progress of its share repurchase program and that its subsidiary, Shanghai Henlius Biotech, secured EU Good Manufacturing Practice (GMP) certification for two key products.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600196•Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime